The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus
PLOS ONE · 15.06.2023 · 18 (6) · e0287373
DOI: 10.1371/journal.pone.0287373 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS ONE, online erschienen am 15.06.2023. Verfasst von Kuo-Cheng Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Neuropathies, Hyperlipidemias. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taichung Veterans General Hospital.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Previous studies showed conflicting relationship between hyperlipidemia, lipid-lowering therapy and diabetic peripheral neuropathy (DPN). As most of these works emerges from the Western and Australian countries, our study aims to investigate whether hyperlipidemia or lipid-lowering therapy (LLT) is associated with DPN in Taiwanese patients with type 2 diabetes (T2D).
Methods
A cross-sectional, hospital-based observation study in adults with T2D was conducted from January to October 2013. DPN was screened using the Michigan Neuropathy Screening Instrument. Data were obtained at the time of enrollment, including medication usage, anthropometric measurements and laboratory examinations.
Results
2,448 participants were enrolled, 524 (21.4%) of whom had DPN. Patients with DPN had significantly lower plasma total cholesterol (185.6 ± 38.6 vs 193.4 ± 42.3 mg/dL) and low-density lipoprotein cholesterol levels (114.6 ± 32.7 vs 119 ± 30.8 mg/dL). Multivariate analysis demonstrated that neither hyperlipidemia (adjusted OR (aOR), 0.81; 95% confidence interval (CI), 0.49–1.34) nor LLT (aOR, 1.10; 95% CI, 0.58–2.09) was associated with DPN. Subgroup analysis revealed that neither total cholesterol (aOR, 0.72; 95% CI, 0.2–2.62), low-density lipoprotein cholesterol levels (aOR, 0.75; 95% CI, 0.2–2.79), statin (aOR, 1.09; 95% CI, 0.59–2.03) nor fibrate (aOR, 1.73; 95% CI, 0.33–1.61) was associated with DPN.
Conclusion
Our results suggest that neither hyperlipidemia nor lipid-lowering medication was associated with DPN in adults with T2D. DPN is a multifactorial disease, and our findings indicate that lipid metabolism may play a minor role in its pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
- Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
- Department of Medicine, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
ORCID-Profile: Ming-Hong Chang
Förderung
- Taichung Veterans General Hospital
Zitieren
APA
Chang, K. C., Pai, Y. W., Lin, C. H., Lee, I. T., & Chang, M. H. (2023). The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. PLOS ONE, 18(6), e0287373. https://doi.org/10.1371/journal.pone.0287373
Vancouver
Chang KC, Pai YW, Lin CH, Lee IT, Chang MH. The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. PLOS ONE. 2023;18(6):e0287373. doi:10.1371/journal.pone.0287373
BibTeX
@article{Chang2023,
author = {Chang, Kuo-Cheng and Pai, Yen-Wei and Lin, Ching-Heng and Lee, I-Te and Chang, Ming-Hong},
title = {The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {6},
pages = {e0287373},
doi = {10.1371/journal.pone.0287373}
}
EUVIMED